Is HR a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Healthcare Realty Trust (HR) rests on Occupancy and leasing momentum: HR reported record quarterly leasing of more than 2 million square feet in Q1 2026 and same-store occupancy of about 92.3 percent, up roughly 110 basis points year over year. Revenue (TTM) is ~$1.2B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Whether HR is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Healthcare Realty Trust is a real estate investment trust focused on outpatient medical facilities, primarily medical office buildings leased to health systems, physician groups, and related healthcare tenants, with properties concentrated on or near acute-care hospital campuses. The company became the largest dedicated owner of medical office real estate after its 2022 combination with Healthcare Trust of America, and it earns rent from a diversified base of healthcare providers whose demand tends to be less cyclical than other property types. The investment picture centers on funds from operations (FFO), occupancy, and the balance sheet rather than rapid growth. Management has been raising occupancy toward the low-90s percent range, growing same-store cash net operating income, and selling assets to pay down debt, while the dividend (a defining feature of most REITs) provides the bulk of the total-return case. Interest rates matter a great deal here: higher-for-longer rates raise financing costs and pressure REIT valuations, so HR is generally viewed through an income-and-stability lens.
What's the case for buying HR?
1. Occupancy and leasing momentum
HR reported record quarterly leasing of more than 2 million square feet in Q1 2026 and same-store occupancy of about 92.3 percent, up roughly 110 basis points year over year. Filling vacant medical office space is the most direct lever on cash flow, and continued lease-up would support internal growth without new acquisitions.
2. Same-store cash NOI growth
The company posted same-store cash NOI growth near 6.9 percent in Q1 2026, described as its highest quarterly increase on record. Management raised full-year same-store cash NOI growth guidance toward a roughly 3.75 to 4.75 percent range, reflecting rent escalators and improving occupancy across a large, mostly on-campus medical office portfolio.
3. Deleveraging and balance sheet repair
HR has been selling assets and repaying debt, bringing net debt to adjusted EBITDA to roughly 5.4x with about 98 percent of debt fixed near a 3.2 percent weighted-average rate and around $1.4 billion of liquidity as of late 2025. A stronger balance sheet lowers refinancing risk and gives more flexibility as debt matures.
4. Durable outpatient demand
The long-term thesis rests on the shift of care toward outpatient settings and an aging population, which supports steady demand for medical office space near hospitals. This tenant base tends to renew leases at high rates, giving HR relatively predictable, recurring rental income.
What are the risks to HR?
As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Its FFO payout leaves limited cushion, and the dividend has been trimmed in the past, so distribution coverage is worth watching. Integration of the large Healthcare Trust of America portfolio, tenant credit and move-outs, and elevated leverage relative to some peers add execution risk. Asset sales used to cut debt can also dilute near-term earnings power. Any broader weakness in commercial real estate values could weigh on the shares.
How is HR valued? (as of JULY 2026)
Snapshot for HR as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Market cap: ~$7.1B
- Revenue (TTM): ~$1.2B
- Normalized FFO/share (Q1 2026): ~$0.41
- FY2026 normalized FFO guidance: ~$1.59-$1.65
- Dividend yield: ~4.7%
- Net debt / adjusted EBITDA: ~5.4x
REITs are usually valued on FFO per share and dividend yield rather than standard price-to-earnings, because large non-cash depreciation charges understate GAAP earnings. HR trades as an income vehicle, with a quarterly dividend near $0.24 per share and a yield in the mid-4-percent range as of mid-2026. Figures are approximate and drawn from recent results and guidance.
How do you decide if HR is a buy?
Rather than asking whether HR is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold HR indirectly through an index or sector ETF before adding more.
For the full picture, see the HR stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HR against your real portfolio and see your actual exposure before deciding.
The bottom line on HR
The bottom line: Healthcare Realty Trust's story right now is Occupancy and leasing momentum, with revenue (ttm) at ~$1.2B. If you believe that narrative continues, the call is about sizing HR sensibly and checking overlap with what you own; if you doubt it (the risk: as a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
More on HR
- HR stock guide (what the company does, ETFs that hold it, similar stocks, and the themes it fits)
- HR stock forecast (the drivers and risks shaping the outlook)
- Does HR pay a dividend?
Build a basket around HR with Walnut
Use Healthcare Realty Trust as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is HR a good stock to buy right now?
+
The case for Healthcare Realty Trust right now is Occupancy and leasing momentum, with revenue (ttm) at ~$1.2B. If you believe that thesis holds, HR is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is as a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Healthcare Realty Trust do?
+
Healthcare Realty Trust is a real estate investment trust focused on outpatient medical facilities, primarily medical office buildings leased to health systems, physician groups, a
What are the main risks of HR?
+
As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Its FFO payout leaves limited cushion, and the dividend has been trimmed in the past, so distribution coverage is worth watching. Integration of the large Healthcare Trust of America portfolio, tenant credit and move-outs, and elevated leverage relative to some peers add execution risk. Asset sales used to cut debt can also dilute near-term earnings power. Any broader weakness in commercial real estate values could weigh on the shares.
What does Healthcare Realty Trust do?
+
It is a REIT that owns and operates outpatient medical facilities, mainly medical office buildings leased to health systems and physician groups, with properties concentrated near acute-care hospital campuses. It collects rent from these healthcare tenants.
Is HR a good dividend stock?
+
HR pays a quarterly dividend, roughly $0.24 per share, for a yield in the mid-4-percent range as of mid-2026. Whether that suits a given investor depends on their income goals and risk tolerance; note the dividend has been reduced in the past when cash flow tightened.
How did HR perform in its latest quarter?
+
In Q1 2026 HR reported normalized FFO of about $0.41 per share, same-store cash NOI growth near 6.9 percent, occupancy around 92.3 percent, and record leasing of more than 2 million square feet, and it raised full-year FFO guidance.
What is FFO and why does it matter for HR?
+
Funds from operations (FFO) adds back real estate depreciation to net income and is the standard measure of a REIT's cash-generating ability. For HR, normalized FFO per share and its guidance are the key numbers investors track rather than GAAP earnings per share.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell HR; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.